Systemic therapy for advanced human epidermal growth factor receptor 2–positive breast cancer: ASCO guideline update
… Quality of the evidence for each outcome was assessed using the Cochrane Risk of Bias tool and elements of the GRADE quality assessment and recommendations development …..... Read More